This strongly suggests that the alternate NPM1 subcellular localization is not driven through any genetic defect but rather through alterations in protein or nucleic acid interactions (through cancer-related mislocalization of interacting partners for instance), protein-targeting signals, transport machinery or post-translational modifications [38]. This evidence concerns the gene NPM1 and cancer.